Cardlytics Accounts Payable vs Net Debt Analysis

CDLX Stock  USD 1.79  0.11  6.55%   
Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Accounts Payable and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Accounts Payable vs Net Debt

Accounts Payable vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Accounts Payable account and Net Debt. At this time, the significance of the direction appears to have weak relationship.
The correlation between Cardlytics' Accounts Payable and Net Debt is 0.31. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Debt in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Accounts Payable and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Cardlytics are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Accounts Payable i.e., Cardlytics' Accounts Payable and Net Debt go up and down completely randomly.

Correlation Coefficient

0.31
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Cardlytics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cardlytics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Cardlytics reported Tax Provision of (1.45 Million) in 2024. Issuance Of Capital Stock is likely to rise to about 81.1 M in 2025, whereas Selling General Administrative is likely to drop slightly above 49.5 M in 2025.
 2022 2023 2024 2025 (projected)
Depreciation And Amortization43.7M29.5M27.9M18.4M
Interest Income1.4M3.8M3.4M3.3M

Cardlytics fundamental ratios Correlations

0.740.970.960.950.670.320.660.880.13-0.540.170.740.97-0.02-0.20.760.740.840.68-0.530.690.320.79-0.220.29
0.740.710.720.610.140.570.40.720.56-0.810.080.580.680.19-0.120.990.580.860.85-0.640.930.540.83-0.230.19
0.970.710.990.90.620.310.530.880.22-0.550.240.620.97-0.07-0.320.740.620.830.64-0.480.650.330.77-0.220.27
0.960.720.990.870.610.30.490.910.25-0.580.350.580.97-0.04-0.420.720.580.810.68-0.40.660.330.79-0.30.21
0.950.610.90.870.640.420.750.81-0.06-0.470.00.80.880.02-0.070.640.80.820.66-0.570.580.020.76-0.150.45
0.670.140.620.610.64-0.40.430.54-0.270.120.220.390.74-0.21-0.120.150.390.230.1-0.140.080.250.180.030.07
0.320.570.310.30.42-0.40.340.350.32-0.77-0.310.450.170.460.090.570.450.730.74-0.580.65-0.270.74-0.110.47
0.660.40.530.490.750.430.340.35-0.44-0.14-0.240.970.49-0.120.30.430.970.510.33-0.370.37-0.040.42-0.260.22
0.880.720.880.910.810.540.350.350.38-0.680.360.460.910.1-0.510.710.460.830.77-0.450.680.280.82-0.370.16
0.130.560.220.25-0.06-0.270.32-0.440.38-0.750.31-0.280.220.48-0.460.52-0.280.360.48-0.230.640.510.52-0.060.03
-0.54-0.81-0.55-0.58-0.470.12-0.77-0.14-0.68-0.75-0.07-0.31-0.5-0.590.3-0.78-0.31-0.82-0.90.57-0.91-0.24-0.930.19-0.26
0.170.080.240.350.00.22-0.31-0.240.360.31-0.07-0.240.32-0.33-0.860.01-0.24-0.05-0.030.61-0.020.340.04-0.49-0.33
0.740.580.620.580.80.390.450.970.46-0.28-0.31-0.240.57-0.050.280.611.00.660.51-0.510.540.080.56-0.240.23
0.970.680.970.970.880.740.170.490.910.22-0.50.320.57-0.04-0.350.690.570.760.61-0.430.620.380.73-0.20.23
-0.020.19-0.07-0.040.02-0.210.46-0.120.10.48-0.59-0.33-0.05-0.040.070.15-0.050.230.47-0.420.49-0.10.470.250.28
-0.2-0.12-0.32-0.42-0.07-0.120.090.3-0.51-0.460.3-0.860.28-0.350.07-0.050.28-0.12-0.14-0.42-0.13-0.22-0.250.620.35
0.760.990.740.720.640.150.570.430.710.52-0.780.010.610.690.15-0.050.610.880.81-0.690.920.530.82-0.180.25
0.740.580.620.580.80.390.450.970.46-0.28-0.31-0.241.00.57-0.050.280.610.660.51-0.510.540.080.56-0.240.23
0.840.860.830.810.820.230.730.510.830.36-0.82-0.050.660.760.23-0.120.880.660.91-0.740.840.170.94-0.180.38
0.680.850.640.680.660.10.740.330.770.48-0.9-0.030.510.610.47-0.140.810.510.91-0.690.860.160.92-0.150.29
-0.53-0.64-0.48-0.4-0.57-0.14-0.58-0.37-0.45-0.230.570.61-0.51-0.43-0.42-0.42-0.69-0.51-0.74-0.69-0.67-0.07-0.65-0.29-0.52
0.690.930.650.660.580.080.650.370.680.64-0.91-0.020.540.620.49-0.130.920.540.840.86-0.670.460.91-0.190.24
0.320.540.330.330.020.25-0.27-0.040.280.51-0.240.340.080.38-0.1-0.220.530.080.170.16-0.070.460.18-0.14-0.42
0.790.830.770.790.760.180.740.420.820.52-0.930.040.560.730.47-0.250.820.560.940.92-0.650.910.18-0.20.38
-0.22-0.23-0.22-0.3-0.150.03-0.11-0.26-0.37-0.060.19-0.49-0.24-0.20.250.62-0.18-0.24-0.18-0.15-0.29-0.19-0.14-0.20.54
0.290.190.270.210.450.070.470.220.160.03-0.26-0.330.230.230.280.350.250.230.380.29-0.520.24-0.420.380.54
Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets422.5M1.3B691.2M574.1M392.7M439.2M
Short Long Term Debt Total188.1M197.2M235.3M266.1M221.7M150.9M
Other Current Liab70.1M313.4M238.5M162.2M95.2M123.4M
Total Current Liabilities81.3M327.4M248.9M171.1M149.0M138.3M
Total Stockholder Equity157.2M690.7M211.6M134.8M70.0M95.9M
Other Liab2.6M679K54.5M334K384.1K364.9K
Net Tangible Assets139.1M150.4M(190.5M)158.1M181.8M190.9M
Property Plant And Equipment Net24.6M21.5M12.5M10.6M8.9M14.1M
Current Deferred Revenue349K3.3M1.8M2.4M2.2M1.4M
Net Debt(105.1M)(36.2M)113.4M174.3M156.1M163.9M
Retained Earnings(394.1M)(522.6M)(976.6M)(1.1B)(1.3B)(1.2B)
Accounts Payable1.4M4.6M3.8M4.4M3.7M3.2M
Cash293.2M233.5M121.9M91.8M65.6M112.4M
Non Current Assets Total36.9M905.1M441.2M350.2M214.7M227.2M
Non Currrent Assets Other5.6M2.4M2.6M2.7M35.0M36.7M
Other Assets10.1M22.6M2.4M2.6M2.3M2.2M
Long Term Debt174.0M184.4M226.0M257.6M167.7M136.2M
Cash And Short Term Investments293.2M233.5M121.9M91.8M65.6M112.4M
Net Receivables86.6M117.2M120.1M126.0M107.1M92.1M
Common Stock Shares Outstanding27.2M32.2M33.4M36.5M48.4M29.5M
Long Term Debt Total13K174.0M184.4M226.0M260.0M273.0M
Liabilities And Stockholders Equity422.5M1.3B691.2M574.1M392.7M439.2M
Non Current Liabilities Total184.1M245.7M230.7M268.2M173.8M205.0M
Capital Surpluse480.6M551.4M1.2B1.2B1.4B1.4B
Inventory129K110K95K80K72K68.4K
Other Current Assets5.8M8.1M8.1M6.1M5.3M7.5M
Other Stockholder Equity551.4M1.2B1.2B1.2B1.4B715.9M
Total Liab265.3M573.1M479.6M439.3M322.7M343.3M
Deferred Long Term Liab8.5M3.8M139K198K178.2K169.3K
Property Plant And Equipment Gross24.6M11.3M5.9M43.7M18.6M16.9M
Total Current Assets385.6M358.7M250.0M223.9M178.0M212.0M
Accumulated Other Comprehensive Income(192K)486K5.6M2.5M3.6M2.1M
Short Term Debt9.5M6.1M4.9M2.1M49.9M52.4M
Intangible Assets6.7M138.7M73.4M59.6M11.4M10.8M
Property Plant Equipment14.3M13.9M21.5M5.9M6.8M12.5M
Capital Lease Obligations14.1M12.8M9.2M8.5M8.1M7.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.